Abstract
Cerebral ischemic postconditioning （IPO） refers to a series of rapid intermittent interruptions of blood flow in the early phase of reperfusion. It protects brain tissue against ischemia-reperfusion injury. IPO decreases infarct volume and neuron loss by activating protein kinases, blocking apoptosis pathways, inhibiting inflammation and oxidative stress. IPO can be applied after cerebral ischemia, and it has better application prospects in clinical practice, This article reviews IPO and its neuroprotective mechanisms. Key words: Brain ischemia; Brain infarction; Reperfusion; Neuroprotective agents; Inflammation; Apoptosis; Oxidative stress; Protein kinases
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
